Suppr超能文献

[慢性阻塞性肺疾病急性加重的资源利用及相关成本:一项基于人群的回顾性研究]

[Use of resources and associated costs of chronic obstructive pulmonary disease exacerbations: A population based retrospective study].

作者信息

Sicras A, Huerta A, Navarro R, Ibañez J

机构信息

Dirección de Planificación, Badalona Serveis Assistencials, Badalona, Barcelona, España.

Departamento de Evaluación de Medicamentos, GlaxoSmithKline, Madrid, España.

出版信息

Semergen. 2014 May-Jun;40(4):189-97. doi: 10.1016/j.semerg.2013.10.002. Epub 2014 Jan 30.

Abstract

OBJECTIVE

Exacerbations are a clinical characteristic of chronic obstructive pulmonary disease (COPD). The objective of the study was to estimate the resource use and costs associated with COPD exacerbations

PATIENTS AND METHODS

Observational study performed by retrospective review of patient clinical charts of a Hospital and 6 associated Primary Care Centers. COPD patients >40years old who were followed-up during 2010-2011, and who fulfilled inclusion/exclusion criteria were included in the study. Healthcare resource use and costs associated to COPD exacerbations (moderate/severe) were estimated. Healthcare resource use, loss of productivity and costs associated to the follow-up of COPD patients (with/without exacerbations) were also estimated.

STATISTICAL ANALYSIS

regression model and ANCOVA, P<.05.

RESULTS

A total of 1,210patients were included in the study, of whom 51.2% experienced an exacerbation, and with an average of 4exacerbations/patient. Presence of exacerbations was associated with age, COPD severity, presence of comorbidities, and time from diagnosis. The average healthcare cost of an exacerbation was €481 (moderate: €375; severe: €863). Patients who experienced an exacerbation had a higher resource use and costs (P<.001). Thus, the follow-up cost of patients without exacerbations was €1,392 versus €3,175 for patients with exacerbations.

CONCLUSION

The presence of exacerbations in COPD patients was associated with an increase in resource use and associated costs.

摘要

目的

急性加重是慢性阻塞性肺疾病(COPD)的临床特征。本研究的目的是评估与COPD急性加重相关的资源利用和成本。

患者与方法

通过回顾一家医院及6个相关初级保健中心的患者临床病历进行观察性研究。纳入2010 - 2011年期间接受随访、年龄>40岁且符合纳入/排除标准的COPD患者。评估与COPD急性加重(中度/重度)相关的医疗资源利用和成本。还评估了与COPD患者随访(有/无急性加重)相关的医疗资源利用、生产力损失和成本。

统计分析

回归模型和协方差分析,P<0.05。

结果

共1210例患者纳入研究,其中51.2%经历过急性加重,平均每位患者有4次急性加重。急性加重的发生与年龄、COPD严重程度、合并症的存在以及诊断时间有关。一次急性加重的平均医疗费用为481欧元(中度:375欧元;重度:863欧元)。经历过急性加重的患者资源利用和成本更高(P<0.001)。因此,无急性加重患者的随访成本为1392欧元,而有急性加重患者为3175欧元。

结论

COPD患者急性加重的存在与资源利用及相关成本的增加有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验